Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine Obesity pharmacotherapy in older adults: a narrative review of evidence International Journal of Obesity Semaglutide vs. Tirzepatide: Which is Better? Rio Glow Aesthetics